Impaired/JJ
cortisol/NN
binding/NN
to/TO
glucocorticoid/NN
receptors/NNS
in/IN
hypertensive/JJ
patients/NNS
./.

We/PRP
compared/VBD
glucocorticoid/NN
receptor/NN
binding/NN
characteristics/NNS
and/CC
glucocorticoid/NN
responsiveness/NN
of/IN
human/JJ
mononuclear/JJ
leukocytes/NNS
(/(
HML/NN
)/)
from/IN
hypertensive/JJ
patients/NNS
and/CC
matched/VBD
normotensive/JJ
volunteers/NNS
./.
=====
We/PRP
also/RB
considered/VBD
associations/NNS
of/IN
these/DT
variables/NNS
with/IN
plasma/NN
renin/NN
activity/NN
,/,
aldosterone/NN
,/,
cortisol/NN
,/,
corticotropin/NN
,/,
and/CC
electrolyte/NN
concentrations/NNS
./.
=====
We/PRP
calculated/VBD
binding/NN
affinity/NN
(/(
Kd/NN
;/:
nmol/L/NN
)/)
and/CC
capacity/NN
(/(
Bmax/NN
;/:
sites/cell/NNS
)/)
for/IN
dexamethasone/NN
and/CC
cortisol/NN
from/IN
homologous/JJ
and/CC
heterologous/JJ
competition/NN
curves/NNS
for/IN
specific/JJ
[3H]dexamethasone/NN
binding/NN
sites/NNS
on/IN
HML/NN
isolated/VBN
from/IN
the/DT
blood/NN
of/IN
normotensive/JJ
volunteers/NNS
and/CC
subjects/NNS
with/IN
essential/JJ
hypertension/NN
./.
=====
Glucocorticoid/NN
responsiveness/NN
of/IN
HML/NN
was/VBD
evaluated/VBN
as/IN
IC50/NN
values/NNS
(/(
nmol/L/NN
)/)
for/IN
dexamethasone/NN
and/CC
cortisol/NN
for/IN
the/DT
inhibition/NN
of/IN
lysozyme/NN
release/NN
./.
=====
We/PRP
measured/VBD
plasma/NN
hormones/NNS
by/IN
radioimmunoassay/NN
./.
=====
Kd/NN
values/NNS
(/(
mean+/-SE/NN
)/)
for/IN
cortisol/NN
in/IN
HML/NN
of/IN
hypertensive/JJ
patients/NNS
were/VBD
higher/JJR
than/IN
in/IN
control/NN
subjects/NNS
(/(
24.6+/-2.4/CD
versus/CC
17.5+/-1.7/CD
nmol/L/NN
,/,
P/NN
</JJR
.04/CD
)/)
./.
=====
Binding/NN
capacity/NN
(/(
4978+/-391/CD
versus/CC
4131+/-321/CD
sites/cell/NNS
)/)
,/,
Kd/NN
values/NNS
for/IN
dexamethasone/NN
(/(
6.7+/-0.5/CD
versus/CC
5.7+/-0.3/CD
nmol/L/NN
)/)
,/,
and/CC
IC50/NN
values/NNS
for/IN
dexamethasone/NN
(/(
3.4+/-0.3/CD
versus/CC
3.1+/-0.2/CD
nmol/L/NN
)/)
and/CC
cortisol/NN
(/(
12.2+/-1.6/CD
versus/CC
9.5+/-0.3/CD
nmol/L/NN
)/)
were/VBD
not/RB
significantly/RB
different/JJ
./.
=====
Patients/NNS
with/IN
renin/NN
values/NNS
less/JJR
than/IN
0.13/CD
ng/NN
angiotensin/NN
I/L/NN
per/IN
second/NN
were/VBD
markedly/RB
less/RBR
sensitive/JJ
to/TO
cortisol/NN
than/IN
those/DT
with/IN
higher/JJR
values/NNS
./.
=====
Both/CC
Kd/NN
(/(
30.3+/-2.5/CD
versus/CC
19.2+/-2.4/CD
nmol/L/NN
)/)
and/CC
IC50/NN
values/NNS
(/(
15.5+/-1.8/CD
versus/CC
8.9+/-1.2/CD
nmol/L/NN
)/)
for/IN
cortisol/NN
were/VBD
significantly/RB
higher/JJR
in/IN
patients/NNS
with/IN
lower/JJR
renin/NN
values/NNS
(/(
P/NN
</JJR
.03/CD
)/)
./.
=====
Other/JJ
variables/NNS
,/,
including/VBG
plasma/NN
hormone/NN
and/CC
electrolyte/NN
values/NNS
and/CC
binding/NN
characteristics/NNS
for/IN
dexamethasone/NN
,/,
were/VBD
not/RB
different/JJ
./.
=====
These/DT
data/NNS
suggest/VBP
that/IN
cortisol/NN
binding/NN
to/TO
glucocorticoid/NN
receptor/NN
is/VBZ
slightly/RB
impaired/JJ
in/IN
patients/NNS
with/IN
essential/JJ
hypertension/NN
./.
=====
In/FW
vivo/FW
,/,
this/DT
could/MD
lead/VB
to/TO
inappropriate/JJ
binding/NN
of/IN
cortisol/NN
to/TO
mineralocorticoid/NN
receptors/NNS
./.
=====
Hence/RB
,/,
decreased/VBN
sensitivity/NN
to/TO
cortisol/NN
is/VBZ
associated/VBN
with/IN
renin/NN
suppression/NN
./.
=====
This/DT
hypothesis/NN
is/VBZ
supported/VBN
by/IN
evidence/NN
of/IN
hypertension/NN
and/CC
low/JJ
renin/NN
activity/NN
,/,
which/WDT
others/NNS
have/VBP
described/VBN
in/IN
patients/NNS
with/IN
primary/JJ
glucocorticoid/NN
resistance/NN
due/JJ
to/TO
mutations/NNS
of/IN
the/DT
glucocorticoid/NN
receptor/NN
./.